Backed by 20 years of use in clinical and emergency settings, CTK’s range of OnSite® Dengue Rapid Tests use state-of-the-art recombinant analytes to detect and differentiate Dengue IgG/IgM antibodies and NS1 antigens across all four serotypes, providing clinicians with point-of-care diagnostic aids with reproducible quality and a high standard f...

The OnSite COVID-19 Ag Rapid Test is a lateral flow immunoassay for the qualitative detection of SARS-CoV-2 virus in nasopharyngeal (NP), or nasal swab specimens from individuals who are suspected of COVID-19, within the first seven days of the onset of symptoms.

The OnSite ® H. pylori Ab Combo Rapid Test is a lateral flow chromatographic immunoassay for the qualitative detection of antibodies against Helicobacter pylori (H. pylori) in human serum, plasma, or whole blood. This antibody detection test is a noninvasive diagnostic method and can be performed within 15 minutes by minimally skilled ...

CTK Biotech develops and manufactures immunodiagnostic tools and point of care diagnostic test kits for medical professionals to quickly and accurately diagnose disease.

2022年7月13日 · The OnSite Dengue Ag rapid Test CE is a lateral flow chromatographic immunoassay for the qualitative detection of dengue NS1 antigen (DEN1, 2, 3, 4) in human serum, plasma or whole...

The OnSite rapid tests are lateral flow immunoassays for the qualitative detection and/or differentiation of antibodies and/or antigens, particularly for pathogens in infectious diseases. Rapid test kits are CE marked and intended for use by …

The OnSite COVID-19 IgG/IgM Rapid Test is a single use lateral flow immunoassay rapid test intended for qualitative detection and differentiation of anti-SARS-CoV-2 IgG and IgM antibodies in human serum and plasma or whole blood containing EDTA, heparin or citrate anti-coagulants.

OnSite® Dengue IgG/IgM Combo Rapid Test | UNBOXING | CTK Biotech. The OnSite Dengue IgG/IgM 3.0 Combo Rapid Test is a lateral flow immunoassay for the simultaneous detection and...

2023年6月15日 · This report describes the clinical evaluation of the OnSite COVID-19 rapid test (CTK Biotech, CA, USA) in Brazil and the United Kingdom. A total of 496 paired nasopharyngeal (NP) swabs were collected from symptomatic health care workers at Hospital das Clínicas in São Paulo, Brazil, and 211 NP swabs were collected from symptomatic ...

The OnSite COVID-19 Ag Rapid Test is a lateral flow immunoassay for the qualitative detection of SARS-CoV-2 nucleocapsid antigens in nasopharyngeal (NP) swab specimens from individuals suspected of COVID-19, within the first seven days of the onset of symptoms.